HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael B Atkins Selected Research

tivozanib

10/2021Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 Study.
12/2020Final Overall Survival Results from a Phase 3 Study to Compare Tivozanib to Sorafenib as Third- or Fourth-line Therapy in Subjects with Metastatic Renal Cell Carcinoma.
1/2020Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael B Atkins Research Topics

Disease

125Neoplasms (Cancer)
10/2022 - 03/2002
116Renal Cell Carcinoma (Grawitz Tumor)
10/2022 - 06/2002
97Melanoma (Melanoma, Malignant)
06/2022 - 06/2002
23Kidney Neoplasms (Kidney Cancer)
10/2022 - 04/2004
19Neoplasm Metastasis (Metastasis)
01/2022 - 01/2003
18Disease Progression
10/2022 - 12/2009
10Brain Neoplasms (Brain Tumor)
12/2021 - 10/2008
8Hypoxia (Hypoxemia)
07/2015 - 02/2005
7Fatigue
10/2021 - 07/2003
6Necrosis
01/2021 - 08/2007
6Hypertension (High Blood Pressure)
12/2020 - 10/2009
6Body Weight (Weight, Body)
01/2019 - 08/2007
4Cardiotoxicity
12/2021 - 02/2009
4Colitis
12/2021 - 04/2015
3Fever (Fevers)
01/2022 - 07/2003
3Uveal melanoma
10/2021 - 01/2019
3COVID-19
01/2021 - 01/2020
3Exanthema (Rash)
01/2021 - 12/2009
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 06/2012
3Inflammation (Inflammations)
01/2021 - 05/2014
3Hypothyroidism
01/2018 - 07/2002
2Hypophysitis
12/2021 - 06/2015
2Neurologic Manifestations (Neurological Manifestations)
11/2021 - 08/2018
2Tics (Tic)
01/2021 - 01/2019
2Pneumonia (Pneumonitis)
01/2020 - 01/2017
2Infections
12/2019 - 05/2014

Drug/Important Bio-Agent (IBA)

39Interleukin-2 (IL2)IBA
07/2015 - 06/2002
32Sunitinib (Sutent)FDA Link
10/2022 - 09/2008
32Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2022 - 02/2005
31Immune Checkpoint InhibitorsIBA
10/2022 - 02/2016
31IpilimumabIBA
01/2022 - 11/2012
30NivolumabIBA
01/2022 - 04/2014
25Sorafenib (BAY 43-9006)FDA Link
10/2021 - 02/2006
22Biomarkers (Surrogate Marker)IBA
10/2022 - 06/2008
18pembrolizumabIBA
10/2022 - 11/2014
18CytokinesIBA
01/2021 - 03/2002
15Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2022 - 01/2007
15Bevacizumab (Avastin)FDA Link
02/2022 - 05/2009
14Axitinib (AG 013736)IBA
10/2022 - 05/2009
13Pharmaceutical PreparationsIBA
01/2021 - 04/2006
9atezolizumabIBA
02/2022 - 11/2014
9B7-H1 AntigenIBA
01/2022 - 02/2015
9InterferonsIBA
03/2017 - 01/2005
8Proteins (Proteins, Gene)FDA Link
10/2021 - 02/2005
8TOR Serine-Threonine KinasesIBA
01/2016 - 03/2004
7Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020 - 06/2014
6LigandsIBA
02/2022 - 06/2012
6Tyrosine Kinase InhibitorsIBA
01/2022 - 05/2006
6Angiogenesis InhibitorsIBA
01/2021 - 01/2007
6Phosphotransferases (Kinase)IBA
01/2021 - 03/2004
6Biological ProductsIBA
01/2021 - 01/2004
6trametinibIBA
11/2020 - 06/2014
6VemurafenibIBA
11/2020 - 02/2013
6temsirolimusFDA Link
01/2016 - 03/2004
5SteroidsIBA
01/2022 - 01/2017
5dabrafenibIBA
11/2020 - 06/2014
5Monoclonal AntibodiesIBA
10/2019 - 07/2009
5Dacarbazine (DIC)FDA LinkGeneric
06/2015 - 10/2002
4AntibodiesIBA
01/2022 - 02/2016
4Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 07/2002
4Alanine Transaminase (SGPT)IBA
12/2021 - 01/2018
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2021 - 05/2004
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2017 - 12/2009
4Peptides (Polypeptides)IBA
09/2017 - 05/2008
4Mitogen-Activated Protein KinasesIBA
09/2016 - 02/2006
4Cisplatin (Platino)FDA LinkGeneric
06/2015 - 10/2002
4Vinblastine (Vinblastine Sulfate)FDA Link
06/2015 - 10/2002
4Interferon alpha-2 (Roferon-A)FDA Link
11/2014 - 01/2005
4Carbonic Anhydrase IXIBA
11/2013 - 01/2009
4Temozolomide (Temodar)FDA LinkGeneric
12/2009 - 10/2002
3avelumabIBA
10/2022 - 01/2018
3tivozanibIBA
10/2021 - 01/2020
3CaspasesIBA
10/2019 - 02/2006
3human ALK1-Fc fusion proteinIBA
01/2019 - 07/2016
3MTOR InhibitorsIBA
01/2014 - 01/2007
3Paclitaxel (Taxol)FDA LinkGeneric
01/2013 - 01/2009
3VaccinesIBA
05/2008 - 03/2002
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2022
2EnzymesIBA
01/2022 - 03/2002
2EverolimusFDA Link
01/2022 - 01/2021
2GemcitabineFDA Link
01/2021 - 10/2015
2Programmed Cell Death 1 ReceptorIBA
01/2021 - 09/2016
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021 - 01/2018
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021 - 04/2015
2Lipase (Acid Lipase)FDA Link
01/2021 - 01/2018
2binimetinibIBA
11/2020 - 07/2015
2cobimetinibIBA
11/2020 - 07/2015
2encorafenibIBA
11/2020 - 07/2015
2CTLA-4 AntigenIBA
10/2020 - 01/2020
2Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
07/2019 - 07/2010

Therapy/Procedure

119Therapeutics
10/2022 - 06/2002
38Immunotherapy
06/2022 - 03/2002
10Drug Therapy (Chemotherapy)
01/2021 - 02/2005
7Nephrectomy
02/2015 - 02/2005
7Biological Therapy
11/2014 - 03/2002
4Aftercare (After-Treatment)
01/2022 - 04/2014
3Injections
01/2021 - 06/2010
2Radiotherapy
01/2021 - 10/2008
2Neoadjuvant Therapy
01/2021 - 11/2020
2Craniotomy
01/2020 - 06/2015